| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |